High Court Ruling Limits International Reach of Patent Laws
The Supreme Court on Wednesday sided with California-based Life Technologies Corp . in a patent infringement case that limits the international reach of U.S. patent laws.
Category Archives: Healthcare Industry
Cardiovascular Systems Inc. (CSII) Stock Rating Upgraded by Zacks Investment Research
The firm presently has a $30.00 price target on the medical device company's stock. Zacks Investment Research's price objective would suggest a potential upside of 21.75% from the company's previous close.
Senators demand better information from DEA on opioid campaign
Seven U.S. senators sharply criticized the Drug Enforcement Administration on Wednesday for failing to answer questions about enforcement actions against pharmaceutical companies accused of violating laws designed to prevent painkillers from reaching the black market. "We received an insufficient response that ignored those questions almost entirely and recited boilerplate information about the DEA's mission," said the letter to the acting DEA administrator, Chuck Rosenberg.
Supreme Court adds 16 cases to docket
The Court granted review on a variety of civil and criminal cases. The civil cases include both substantive and procedural questions.
This Marijuana Company’s in Hot Water With the DOJ
Ongoing investigations into the marketing of its once high-flying fentanyl spray, Subsys, have taken a lot of the luster off Insys Therapeutics ' attempt to reshape marijuana's use as medicine. Today, investigations by the Justice Department led to the arrest of former Insys Therapeutics employees, including former CEO Michael Babich, casting more uncertainty on this company's future.
Trump Is Brexit 2.0: Election Promises Go In The Trash
The pro-Brexit promises were that Brexit would be so awesome because it would fund the tremendously popular single-payer National Healthcare program in Britain. But it's not like the pro-leavers put it on the side of a bus or anything.
Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who…
The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased American Depositary Shares of Teva between February 10, 2015 and November 3, 2016 . The case, Galmi v. Teva Pharmaceutical Industries Limited et al , No.
Bernie Is So Not Done
If you're feeling bereft, take note: Bernie Sanders is still here loudly fighting the good fight, this week blasting the avarice of Big Pharma so persuasively he sent their stock prices plunging to a seven-month low. After battling Big Pharma for decades - pillorying the makers of the emergency allergy injection EpiPen for obscenely jacking up their prices, recently calling out another company's price hikes on leukemia drugs, and campaigning this fall to stop price-gouging by seen by many as Ground Zero for drug companies and their 1,266 D.C. lobbyists - Bernie isn't letting up.
Sanders Takes Aim at Insulin Makers in Latest Price Attack
Makers of insulin became the latest target for Senator Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices. Shares of Eli Lilly & Co.
Eli Lilly (LLY) Stock Falls, Sanders Criticizes Drug Pricing
Shares of Eli Lilly were sliding in early-afternoon trading on Tuesday after Senator Bernie Sanders criticized the price increase of the company's Humalog insulin. Why has the price of Humalog insulin gone up 700% in 20 years? It's simple.
Realistically, Clinton Is Not Anti-Healthcare-Stocks
These bearish sentiments first started with Valeant Pharmaceuticals, then Gilead and Turing Pharmaceuticals, and are now adversely affecting ETFs that hold any of these or their peers/competitors. It is my contention that the market is accustomed to common arbitrage opportunities, and when an even-driven opportunity emerges masking itself as a headwind, investors flee.
US stocks jump as energy companies and Apple move higher
U.S. stocks are climbing in Monday trading as energy companies rise in tandem with the price of oil. Materials companies are also moving up.
Cardiovascular Systems Inc. (CSII) Upgraded at Zacks Investment Research
The brokerage currently has a $27.00 price target on the medical device company's stock. Zacks Investment Research's target price would suggest a potential upside of 13.66% from the company's current price.
EpiPen investigation shows need for greater pricing transparency, other reforms
For months, my office has heard from families concerned about their ability to afford a device they desperately need in the event that a loved one suffers a sudden allergic reaction. Parents should not have to worry about whether they can afford an EpiPen for their children.
For Pfizer, Bigger as One May Be Better Than Smaller With Two
By deciding not to split in two after a lengthy evaluation, the New York-based drugmaker is keeping greater leverage with the health insurers and pharmacy benefit managers that have gained increasing power since it first considered a breakup years ago. Had it broken up, Pfizer would have turned into one company with older and generic products, and another with newer products.
Mylan CEO Faces Tough Questioning in EpiPen Hearing
Mylan NV CEO Heather Bresch faced tough questioning Wednesday from Republicans and Democrats in Congress probing price increases for the EpiPen allergy treatment.
Mylan CEO says company has no plans to lower price of EpiPens
Mylan CEO Heather Bresch takes her seat on Capitol Hill in Washington, Wednesday prior to testifying before the House Oversight Committee hearing on EpiPen price increases. Bresch defended the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers.
Mylan CEO set to defend EpiPen prices amid public outcry
The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. "Price and access exist in a balance, and we believe we have struck that balance," Heather Bresch says in prepared testimony released by the House Oversight and Government Reform Committee ahead of her Wednesday appearance before the panel.
Mylan CEO defends EpiPen prices
In this file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento Mylan CEO Heather Bresch is defending the cost for life-saving EpiPens and is offering no suggestion that there are plans to lower prices. Bresch's prepared testimony was released by the House Oversight and Government Reform Committee ahead of her Sept.
Paterson’s First Hospital Celebrates 150 Years
PATERSON, NJ [September 19, 2016] - St. Joseph's Healthcare System, New Jersey's premier Catholic healthcare system, launched a year-long series of 150th Anniversary celebrations on Thursday, September 8th with the unveiling of a historic marker to commemorate the humble beginnings of St. Joseph's Hospital. Paterson's first hospital, now known as St. Joseph's Regional Medical Center, a member of the Healthcare System, was established by the Sisters of Charity of Saint Elizabeth on September 8, 1867, in response to the industrialized City's dire need for carea body, mind and spirit.